Qiaonan Shan
NHC Key Laboratory Of Combined Multi Organ Transplantation
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Pre-operative risk assessment of hepatocellular carcinoma recurrence in liver transplant recipients by non-invasive detection of pre-existing genetic lesions.
Journal: Clinical and molecular hepatology
Published: September 24, 2025
Regulated Cell Death in Lenvatinib Resistance of Hepatocellular Carcinoma: from Molecular Mechanisms to Therapeutic Strategies.
Journal: International journal of biological sciences
Published: November 19, 2024
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: January 25, 2024
Multi-omic analysis reveals a CAF-stemness-governed classification in HCC liver transplant recipients beyond the Milan criteria.
Journal: Nature communications
Published: June 30, 2023
E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: March 16, 2022
Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 10, 2021
Self-Activated Cascade-Responsive Sorafenib and USP22 shRNA Co-Delivery System for Synergetic Hepatocellular Carcinoma Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 10, 2020
Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria.
Journal: Annals of translational medicine
Published: March 17, 2020
Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma.
Journal: Digestive diseases and sciences
Published: July 03, 2019
Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I.
Journal: Cell death & disease
Published: July 12, 2017
USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway.
Journal: Molecular oncology
Published: February 19, 2017
Last Updated: 09/26/2026